2cureX
2cureX's IndiTreat test grows a patient's tumour cells as microtumours and tests approved drugs on them, available through hospitals in Denmark, Germany, Sweden and the United Kingdom.
Overview
2cureX develops products for individualised therapy selection in oncology. Its IndiTreat technology uses 3D cell cultures of the patient's own tumour to test drugs and drug combinations, and is offered through hospitals in Denmark, Germany, Sweden and the UK, physician-ordered.
Similar pages
not linked directly; found by shared links- CompanyCure-First
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySageMedic
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySpeciCare
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyFirst Ascent Biomedical
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKYAN Technologies
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyStoreMyTumor
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyTravera
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKiyatec
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.